Amicus Therapeutics
Latest round
- Series D
Last raised
- Sep 2006
Total raised
- $123M
Investors
- 9
About Amicus Therapeutics
Based in New Jersey, US, and founded in 2002 by John F. Crowley, Amicus Therapeutics, Inc. operates as a biotechnology company providing medicine for rare metabolic diseases, including a rare disease gene therapy.21 million in Amicus Therapeutics, Inc. Amicus Therapeutics, Inc. developed a product known as galafold, that allows healthcare professionals to treat and diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data. The company offers pombiliti + opfolda for the treatment of adult patients with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency) weighing. In addition, the firm provides program known as amicus assist, that provides personalized support to individuals who have been prescribed an Amicus medication.
Who invested in Amicus Therapeutics
9 investors across 4 rounds
See all investors in Amicus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Amicus Therapeutics
Who invested in Amicus Therapeutics?
Amicus Therapeutics has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amicus Therapeutics raised?
Amicus Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Amicus Therapeutics last raise money?
Amicus Therapeutics's most recent round on record is a Series D, in Sep 2006.
What does Amicus Therapeutics do?
Based in New Jersey, US, and founded in 2002 by John F.
Where is Amicus Therapeutics headquartered?
Amicus Therapeutics is headquartered in US.
Which VCs invest in companies like Amicus Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Amicus Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Amicus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.